IFRX
Price
$1.76
Change
+$0.16 (+10.00%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
108.4M
58 days until earnings call
SVRA
Price
$3.31
Change
+$0.03 (+0.91%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
566.91M
65 days until earnings call
Interact to see
Advertisement

IFRX vs SVRA

Header iconIFRX vs SVRA Comparison
Open Charts IFRX vs SVRABanner chart's image
InflaRx
Price$1.76
Change+$0.16 (+10.00%)
Volume$15.63K
Capitalization108.4M
Savara
Price$3.31
Change+$0.03 (+0.91%)
Volume$15.59K
Capitalization566.91M
IFRX vs SVRA Comparison Chart in %
Loading...
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IFRX vs. SVRA commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFRX is a StrongBuy and SVRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (IFRX: $1.60 vs. SVRA: $3.28)
Brand notoriety: IFRX and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IFRX: 989% vs. SVRA: 57%
Market capitalization -- IFRX: $118.56M vs. SVRA: $572.09M
IFRX [@Biotechnology] is valued at $118.56M. SVRA’s [@Biotechnology] market capitalization is $572.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IFRX’s FA Score shows that 0 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • IFRX’s FA Score: 0 green, 5 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, both IFRX and SVRA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IFRX’s TA Score shows that 5 TA indicator(s) are bullish while SVRA’s TA Score has 3 bullish TA indicator(s).

  • IFRX’s TA Score: 5 bullish, 5 bearish.
  • SVRA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IFRX is a better buy in the short-term than SVRA.

Price Growth

IFRX (@Biotechnology) experienced а +75.15% price change this week, while SVRA (@Biotechnology) price change was +3.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

IFRX is expected to report earnings on Oct 30, 2025.

SVRA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($567M) has a higher market cap than IFRX($108M). SVRA YTD gains are higher at: 6.840 vs. IFRX (-35.223). IFRX has higher annual earnings (EBITDA): -44.6M vs. SVRA (-116.49M). SVRA has more cash in the bank: 146M vs. IFRX (48M). IFRX has less debt than SVRA: IFRX (599K) vs SVRA (29.7M). IFRX has higher revenues than SVRA: IFRX (163K) vs SVRA (0).
IFRXSVRAIFRX / SVRA
Capitalization108M567M19%
EBITDA-44.6M-116.49M38%
Gain YTD-35.2236.840-515%
P/E RatioN/AN/A-
Revenue163K0-
Total Cash48M146M33%
Total Debt599K29.7M2%
FUNDAMENTALS RATINGS
IFRX vs SVRA: Fundamental Ratings
IFRX
SVRA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
10074
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
3640
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SVRA's Valuation (69) in the Biotechnology industry is in the same range as IFRX (70). This means that SVRA’s stock grew similarly to IFRX’s over the last 12 months.

SVRA's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as IFRX (100). This means that SVRA’s stock grew similarly to IFRX’s over the last 12 months.

IFRX's SMR Rating (98) in the Biotechnology industry is in the same range as SVRA (99). This means that IFRX’s stock grew similarly to SVRA’s over the last 12 months.

IFRX's Price Growth Rating (36) in the Biotechnology industry is in the same range as SVRA (40). This means that IFRX’s stock grew similarly to SVRA’s over the last 12 months.

IFRX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SVRA (100). This means that IFRX’s stock grew similarly to SVRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IFRXSVRA
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
73%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
73%
MACD
ODDS (%)
Bullish Trend 5 days ago
78%
N/A
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 26 days ago
86%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
82%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNDCF9.37N/A
N/A
Canadian Banc Corp
HPHTY5.90N/A
N/A
Hamamatsu Photonics
BLMWF0.80N/A
N/A
BluMetric Environmental, Inc.
SINGY10.19-0.04
-0.39%
Singapore Airlines Ltd.
WDFCF0.10-0.01
-9.35%
K9 Gold Corp.

IFRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IFRX has been loosely correlated with PRTA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if IFRX jumps, then PRTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
+36.75%
PRTA - IFRX
34%
Loosely correlated
-0.49%
RCUS - IFRX
28%
Poorly correlated
-0.19%
VERA - IFRX
28%
Poorly correlated
-2.92%
NMRA - IFRX
26%
Poorly correlated
-1.70%
ARWR - IFRX
26%
Poorly correlated
-1.39%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
+0.31%
RCKT - SVRA
60%
Loosely correlated
-2.09%
PRTA - SVRA
45%
Loosely correlated
-0.49%
RVMD - SVRA
40%
Loosely correlated
-0.93%
OCUL - SVRA
39%
Loosely correlated
-2.48%
IFRX - SVRA
39%
Loosely correlated
+36.75%
More